| NDC Code: |
0942-6336 |
| Proprietary Name: |
CPDA-1 |
| Suffix: |
|
| Non-Proprietary Name: |
Anticoagulant Citrate Phosphate Dextrose Adenine |
| Dosage Form: |
SOLUTION |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
21-06-2010 |
| Category Name: |
NDA |
| Application Number: |
BN770420 |
| Labeler: |
FENWAL, INC. |
| Substance Name: |
ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Active Numerator Strength: |
17.3; 206; 2.01; 140; 1.66 |
| Active Ingredient Unit: |
mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL |
| Pharm Classes: |
Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| DEA Schedule: |
|
